Mifepristone's Future Under New FDA Head
Global News Today | 2 Min News | The Daily News Now!
- Published
- May 2, 2026
- Duration
- 1:53
- Summary source
- description
- Last updated
- May 3, 2026
Discusses daily.
Summary
Dr. Marty Makary confirmed as FDA head, but his stance on mifepristone remains unclear. The abortion pill, approved in 2000, has seen restrictions ease over time due to its safety and effectiveness. Critics argue for stricter rules, but data shows serious complications are rare, occurring in less than 0.32% of patients. With over 6 million uses, deaths li…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Dr. Marty Makary confirmed as FDA head, but his stance on mifepristone remains unclear. The abortion pill, approved in 2000, has seen restrictions ease over time due to its safety and effectiveness. Critics argue for stricter rules, but data shows serious complications are rare, occurring in less than 0.32% of patients. With over 6 million uses, deaths linked to the pill are comparable to ibuprofen. As Makary takes office, the future of mifepristone access hangs in the balance. Support the show:
Themes
- daily